Non-IPF Progressive Fibrosing Interstitial Lung Disease (PF-ILD): The Patient Journey

Laflamme Karina; Wijsenbeek Marlies; Kreuter Michael; Fischer Aryeh; Quaresma Manuel

首页> 外文期刊>The Journal of rheumatology >Non-IPF Progressive Fibrosing Interstitial Lung Disease (PF-ILD): The Patient Journey

【24h】

Non-IPF Progressive Fibrosing Interstitial Lung Disease (PF-ILD): The Patient Journey

机译：非IPF渐进式抗体间质肺病（PF-ILD）：患者之旅

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of rheumatology》 |2019年第7期|共1页
作者
Laflamme Karina; Wijsenbeek Marlies; Kreuter Michael; Fischer Aryeh; Quaresma Manuel;
展开▼
作者单位

Boehringer Ingelheim Canada Ltd Burlington ON Canada;

Univ Med Ctr Erasmus MC Rotterdam Netherlands;

Heidelberg Univ Heidelberg Germany;

Univ Colorado Denver CO 80202 USA;

Boehringer Ingelheim Pharma GmbH &

Co KG Ingelheim Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Non-IPF Progressive Fibrosing Interstitial Lung Disease (PF-ILD): The Patient Journey [J] . Laflamme Karina, Wijsenbeek Marlies, Kreuter Michael, The Journal of rheumatology . 2019,第7期

机译：非IPF渐进式抗体间质肺病（PF-ILD）：患者之旅
2. Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease [J] . Athol U Wells, Simon Walsh, Florence Le Maulf, BMJ Open Respiratory Research . 2017,第1期

机译：PF-ILD试验的设计：Nintedanib在进行性纤维化间质性肺疾病患者中的双盲，随机，安慰剂对照的III期临床试验
3. Current Treatment of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease [J] . Opuni Kwabena, Kreuter Michael, Quaresma Manuel, The Journal of rheumatology . 2019,第7期

机译：目前对非IPF渐进式抗体间质肺病患者的治疗方法
4. Longitudinal Alignment of Disease Progression in Fibrosing Interstitial Lung Disease [C] . Wolf-Dieter Vogl, Helmut Prosch, Christina Mueller-Mang, International conference on medical imaging computing and computer-assisted intervention . 2014

机译：纤维化间质性肺疾病疾病进展的纵向比对
5. Occupational Exposures and Subclinical Interstitial Lung Disease: The Mesa (Multi-Ethnic Study of Atherosclerosis) Air-Lung Study [D] . Sack, Coralynn. 2018

机译：职业暴露与亚临床间质性肺病：梅萨（动脉粥样硬化的多民族研究）空气肺研究
6. Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases [O] . Sebastiano Emanuele Torrisi, Nicolas Kahn, Julia Wälscher, 2019

机译：抗纤维化药物在进行性纤维化非IPF间质性肺疾病中的可能价值
7. Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease. [O] . Flaherty, KR, Brown, KK, Wells, AU, 2017

机译：pF-ILD试验的设计：对进行性纤维化间质性肺病患者进行的双盲，随机，安慰剂对照III期试验。

Non-IPF Progressive Fibrosing Interstitial Lung Disease (PF-ILD): The Patient Journey

著录项

相似文献

相关主题

期刊订阅